72,234 articles
Imidapril
Imidapril (Tanatril) is a long-acting prodrug ACE inhibitor, activated to imidaprilat in the liver, used for hypertension, renal parenchymal hypertension, type 1 diabetic nephropathy, and chronic heart failure; first approved 1993.
Imidazole glycerol phosphate synthase, subunit H
HisH is the glutamine amidotransferase (class I GATase) subunit of bacterial imidazole glycerol phosphate synthase; with HisF it converts PRFAR and glutamine to IGP, AICAR, and glutamate, channeling ammonia about 25 Å between active sites.
Imidazoleglycerol-phosphate dehydratase
Imidazoleglycerol-phosphate dehydratase (IGPD, EC 4.2.1.19; HISN5/HIS3/HisB) is a Mn(II)-dependent 24-meric enzyme catalyzing the sixth step of histidine biosynthesis in plants and microbes, a herbicide and antimicrobial drug target.
Imiglitazar
Imiglitazar (TAK-559) is a Takeda dual PPARα/γ agonist (glitazar) for type 2 diabetes; phase 3 development was discontinued in 2004 after liver enzyme abnormalities, and it was never approved.
Imiglucerase
Imiglucerase (Cerezyme) is a CHO-cell recombinant glucocerebrosidase for intravenous enzyme replacement therapy in non-neuronopathic Gaucher disease, FDA-approved 1994, dosed 60 U/kg every other week.
Iminoctadine
Iminoctadine (双胍辛胺), a bis-guanidine FRAC M07 multi-site fungicide (CAS 13516-27-3), sold as triacetate and tris(albesilate) salts; used in Asia and South America for citrus postharvest decay, anthracnose, and powdery mildew; not EU-approved.
Iminoglycinuria
Iminoglycinuria (OMIM 242600) is a rare benign autosomal recessive renal tubular transport defect causing excess urinary glycine, proline, and hydroxyproline with normal plasma levels, mainly from SLC36A2 mutations.
Iminophenyl-pyruvate dimer synthase
Iminophenyl-pyruvate dimer synthase, or VioB, is the heme b enzyme of the violacein pathway that dimerizes indole-3-pyruvate imine into a short-lived dimer, homologous to RebD and StaD.
Imipramine
Imipramine (Tofranil), the first tricyclic antidepressant, discovered by Roland Kuhn at Münsterlingen from Geigy compound G22355; FDA approved 1959; inhibits norepinephrine and serotonin reuptake; used for depression and childhood enuresis.
Imiquimod
Imiquimod (Aldara, Zyclara) is a topical imidazoquinoline immune response modifier and TLR7/8 agonist approved since 1997 for genital warts, actinic keratosis, and superficial basal cell carcinoma.
Imitoceras
Imitoceras, an extinct goniatitid ammonoid genus named by Schindewolf in 1923, type species Ammonites rotatorius; discoidal to globular Prionoceratidae shells from the Upper Devonian to Permian, widespread in Europe, North Africa, and North America.
Imlifidase
Imlifidase (IdeS, Idefirix) is a recombinant Streptococcus pyogenes cysteine protease that cleaves all human IgG, conditionally EU-approved since 2020 to desensitize highly sensitized kidney transplant patients with positive crossmatch before deceased-donor transplantation.
IMM2510
IMM2510 (palverafusp alfa, AXN-2510) is ImmuneOnco's PD-L1 x VEGF bispecific antibody fusion protein using a VEGFR1 trap and ADCC-enhanced Fc; RP2D 20 mg/kg Q2W, tested in NSCLC, sarcoma, and TNBC.
IMM27M
IMM27M (tazlestobart) is ImmuneOnco's humanized Fc-engineered, ADCC-enhanced anti-CTLA-4 IgG1 antibody for advanced solid tumors; Phase I RP2D 5 mg/kg Q3W, formerly licensed to Instil Bio's Axion Bio outside Greater China.
Immature B cell
Immature B cell (newly formed B cell): a bone marrow B lymphocyte, surface IgM-positive and IgD-negative, not yet class-switched or antigen-exposed; screened by central tolerance through receptor editing and clonal deletion before becoming a transitional B cell.
Immature microglial cell
Immature microglial cell (CL:0002628), also called immature, quiescent, or resting microglia: a developmental, ramified microglial cell type, CD34-positive and CD163-, MHCI-, MHCII-negative, arising from yolk sac precursors.
Immature neutrophil
Immature neutrophil (Cell Ontology CL:0000776): developing neutrophil forms such as myelocytes, metamyelocytes, and band cells with specific granules but incomplete maturation; released in left shift during sepsis, inflammation, and cancer.
IMMDC study
IMMDC (NCT04302363), Analysis of Intestinal Microflora Combined With DNA Methylation in Stool to Detect Colorectal Cancer, an observational case-control study at Xiangya Hospital, China, building a CRC screening model from 16S rRNA fecal microbiota plus exfoliated-cell DNA methylation in 500 participants.
Immediate early response
Immediate early response (IER): rapid cellular gene-expression program in which immediate-early genes (c-fos, c-jun, Egr-1, Arc, IER3) are transcribed within minutes of stimulation without new protein synthesis, via ERK/MAPK signaling.
Immediate implant placement
Immediate implant placement is a dental procedure in which an implant is inserted into the fresh extraction socket on the same day as tooth removal.
Immediate-Early Genes
Immediate-early genes (IEGs, primary response genes) are genes expressed rapidly and transiently without new protein synthesis, first named for viral genes; cellular examples include FOS, JUN, EGR1/Zif268, and Arc, central to memory and used as neuronal activity markers.
Immobilized enzyme
Immobilized enzyme: an enzyme fixed to or within a solid support or compartment for reuse and easy separation. Methods include adsorption, entrapment, encapsulation, covalent binding, and cross-linking; used in food, pharma, and wastewater industries.
Immobilized metal affinity chromatography
Immobilized metal affinity chromatography (IMAC) is a protein purification technique separating proteins by affinity for metal ions chelated to a solid support, used mainly to purify His-tagged recombinant proteins in one step.
Immobilized yeast fermentation
Immobilized yeast fermentation is a technique that confines yeast cells, usually Saccharomyces cerevisiae, to a carrier inside a bioreactor, enabling continuous, high-density sugar conversion for bioethanol and beverages.
Immobilized-cell and fixed-bed bioreactors
Immobilized-cell and fixed-bed bioreactors are bioreactors that retain cells or enzymes on carrier material while medium flows past, giving very high cell densities and productivities, and running for months in viral-vector and vaccine manufacturing.
Immortalised cell line
Immortalised cell line (continuous cell line): cells engineered or mutated to divide indefinitely, first achieved with HeLa in 1951; made via telomerase (TERT), SV40, or HPV oncoproteins; authenticated by STR profiling; ICLAC lists 486 misidentified lines.
Immune Adherence Reaction
Immune adherence reaction: antibody- and complement-dependent binding of C3b-coated antigen to C3b receptor cells (CR1, CD35), mainly primate erythrocytes; basis of the IAHA serology test.
Immune challenge
An immune challenge presents the immune system with a defined stimulus, such as endotoxin or a live pathogen, and measures the response, spanning human infection models, rodent protocols, and wild-bird studies.
Immune checkpoint blockade
Immune checkpoint blockade, also called immune checkpoint therapy, is a cancer immunotherapy that uses monoclonal antibodies to block CTLA-4 or PD-1, reactivating suppressed antitumor T cells.
Immune checkpoint inhibitor therapy
Immune checkpoint inhibitor therapy is a cancer treatment using antibodies that block CTLA-4, PD-1, or PD-L1, releasing anti-tumor immune activity; ipilimumab was first approved in 2011.